Loading clinical trials...
Loading clinical trials...
The current study will investigate whether long term implementation of expanded hemodialysis (HDx) will effectively decrease serum levels of large uremic toxins and ameliorate progression of sarcopeni...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gangnam Severance Hospital
NCT06660277 · Chronic Kidney Disease Requiring Hemodialysis, End-Stage Kidney Disease (ESKD), and more
NCT06040281 · Chronic Kidney Disease Requiring Chronic Dialysis
NCT06873880 · Chronic Kidney Disease Requiring Chronic Dialysis
NCT04721652 · Chronic Kidney Disease Requiring Chronic Dialysis, Interdialytic Weight Gain
NCT06225544 · Haemodialysis, Chronic Kidney Disease Requiring Chronic Dialysis, and more
Gangnam Severance Hospital
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions